UNSPSC 51453011: Piperazine hexahydrate

This classification denotes an antihelminthic agent C4H10N2.6H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3M07B8U64, chemically known as piperazine, hydrate (1:6), but more generally known as piperazine hexahydrate, which bears US NIH Compound Identifier 120181. European Medicines Agency schedules Piperazine hexahydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14886MIG. Most nations, for tariff and trade purposes, schedule piperazine hexahydrate under HS 29335990 and SITC 51576.

As of Q4 2014, PIPERAZINE HEXAHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CNCCN1.O.O.O.O.O.O.

UNSPSC 51453011 Piperazine hexahydrate is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally covers a specific chemical compound used in pharmaceutical manufacturing and industrial applications, yet the recent opportunities posted under this code involve finished pharmaceutical products and public health supplies rather than raw piperazine hexahydrate itself. State and local governments do acquire chemical inputs and pharmaceutical raw materials, but the indexed opportunities here—an Illinois Department of Public Health pharmaceutical warehouse contract for antibiotics and a Seminole County procurement for naloxone and drug deactivation systems—represent finished goods or end-use medical products, not the chemical precursor the code describes. The issuing bodies in the recent sample span a state health department and a county health authority, suggesting that state and local health agencies drive activity in pharmaceutical-adjacent codes, though the mismatch between the code's nominal scope and actual solicitation content limits confidence in the representativeness of these opportunities.

The geographic spread appears concentrated in the Southeast and Midwest, with activity from Florida and Illinois in the recent record. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 via IFB for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets on a 12-month initial term with renewal options. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 with a response deadline of July 26, 2023 for 1,900 units of naloxone and 800 safe drug deactivation systems annually, requiring quarterly delivery to the Seminole County Community Health Building with vendor-paid shipping. Neither opportunity matches the code's stated chemical commodity, and no open solicitation for piperazine hexahydrate itself appears in the recent-opportunities block. The code warrants close examination before pursuit — confirm whether state and local agencies actively procure the raw chemical under this code, or whether the indexed opportunities reflect a classification mismatch in the underlying data.